Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001193125-26-253740

Kirn David sold 1,922 shares at $10.02 ($19,258)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kirn David

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-01 Sale : show line 1 in the form 10b5-1 −1,922 $10.02 $19,258 1,057,231 D
Open-market sales · 1,922 sh · avg $10.02 · $19,258
Loading xslF345X06/ownership.xml…